NCT05569876

The HypoVoice Study

Vocal Biomarkers for the Detection and Prevention of Hypoglycemia (HypoVoice)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 7 (actual)
• Sponsor: Insel Gruppe AG, University Hospital Bern · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The HypoVoice study aims at identifying potential vocal biomarkers associated with hypoglycemia to pave the way towards a voice-based hypoglycemia detection approach.

Detailed description

While hypoglycemia has been widely studied in medical research, studies assessing vocal changes associated with this state are limited. This study aims at collecting a data set labelled with the gold standard (blood glucose) to provide a solid basis for the identification of vocal biomarkers using machine learning. Additionally, physiological data are collected using wearable sensors to assess whether additional integration of vital signs (e.g. heart rate) enhances the performance of hypoglycemia detection.

Conditions

• Diabetes Mellitus
• Hypoglycemia

Interventions

Type	Name	Description
OTHER	Controlled hypoglycemic state	Voice sampling is performed in different glycemic states (euglycemia and hypoglycemia).

Timeline

• Start date: 2022-11-11
• Primary completion: 2023-01-31
• Completion: 2023-01-31
• First posted: 2022-10-06
• Last updated: 2023-03-10

Locations

1 site across 1 country: Switzerland